IRGRILHDGAYSLTLQGLGIH
IRGRILHDGAYSLTLQGLGIH is a multi-epitope class II rat HER2/neu peptide. IRGRILHDGAYSLTLQGLGIH can be used for the research class II HER2-DC1 vaccine studies[1].
Product Specifications
CAS Number
1443436-79-0
UNSPSC
12352209
Target
Others
Type
Peptides
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/irgrilhdgaysltlqglgih.html
Solubility
10 mM in DMSO
Smiles
[C@@H](CC1=CN=CN1)(NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@H]([C@H](CC)C)N)=O)CCCNC(=N)N)=O)=O)CCCNC(=N)N)=O)[C@H](CC)C)=O)CC(C)C)=O)C(N[C@H](C(NCC(N[C@H](C(N[C@@H](CC2=CC=C(O)C=C2)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(NCC(N[C@H](C(N[C@@H](CC3=CN=CN3)C(O)=O)=O)[C@H](CC)C)=O)=O)CC(C)C)=O)=O)CCC(N)=O)=O)CC(C)C)=O)[C@@H](C)O)=O)CC(C)C)=O)CO)=O)=O)C)=O)=O)CC(O)=O)=O
Molecular Formula
C102H168N32O28
Molecular Weight
2290.62
References & Citations
[1]Kodumudi KN, et, al. Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response. Front Immunol. 2019 Aug 14;10:1939.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog